436 related articles for article (PubMed ID: 30157718)
21. Cellular subtype expression and activation of CaMKII regulate the fate of atherosclerotic plaque.
Maione AS; Cipolletta E; Sorriento D; Borriello F; Soprano M; Rusciano MR; D'Esposito V; Markabaoui AK; De Palma GD; Martino G; Maresca L; Nobile G; Campiglia P; Formisano P; Ciccarelli M; Marone G; Trimarco B; Iaccarino G; Illario M
Atherosclerosis; 2017 Jan; 256():53-61. PubMed ID: 28011257
[TBL] [Abstract][Full Text] [Related]
22. Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling.
Schwanekamp JA; Lorts A; Vagnozzi RJ; Vanhoutte D; Molkentin JD
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):60-8. PubMed ID: 26564821
[TBL] [Abstract][Full Text] [Related]
23. Counteractive effects of omentin-1 against atherogenesis†.
Watanabe K; Watanabe R; Konii H; Shirai R; Sato K; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
Cardiovasc Res; 2016 May; 110(1):118-28. PubMed ID: 26790473
[TBL] [Abstract][Full Text] [Related]
24. NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.
She ZG; Chang Y; Pang HB; Han W; Chen HZ; Smith JW; Stallcup WB
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):49-59. PubMed ID: 26543095
[TBL] [Abstract][Full Text] [Related]
25. Beyond the Foam Cell: The Role of LXRs in Preventing Atherogenesis.
Rasheed A; Cummins CL
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087224
[TBL] [Abstract][Full Text] [Related]
26. Atherosclerosis: nexus of vascular dynamics and cellular cross talks.
Dasagrandhi D; Muthuswamy A; Swaminathan JK
Mol Cell Biochem; 2022 Feb; 477(2):571-584. PubMed ID: 34845570
[TBL] [Abstract][Full Text] [Related]
27. Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis.
Johnson JL
Cardiovasc Res; 2014 Sep; 103(4):452-60. PubMed ID: 25053639
[TBL] [Abstract][Full Text] [Related]
28. Vascular smooth muscle cells enhance immune/vascular interplay in a 3-cell model of vascular inflammation.
Wiejak J; Murphy FA; Maffia P; Yarwood SJ
Sci Rep; 2023 Sep; 13(1):15889. PubMed ID: 37741880
[TBL] [Abstract][Full Text] [Related]
29. Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation.
Edsfeldt A; Dunér P; Ståhlman M; Mollet IG; Asciutto G; Grufman H; Nitulescu M; Persson AF; Fisher RM; Melander O; Orho-Melander M; Borén J; Nilsson J; Gonçalves I
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1132-40. PubMed ID: 27055903
[TBL] [Abstract][Full Text] [Related]
30. Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis.
Mallavia B; Recio C; Oguiza A; Ortiz-Muñoz G; Lazaro I; Lopez-Parra V; Lopez-Franco O; Schindler S; Depping R; Egido J; Gomez-Guerrero C
Am J Pathol; 2013 May; 182(5):1910-21. PubMed ID: 23597852
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-155 in the pathogenesis of atherosclerosis: a conflicting role?
Ma X; Ma C; Zheng X
Heart Lung Circ; 2013 Oct; 22(10):811-8. PubMed ID: 23827206
[TBL] [Abstract][Full Text] [Related]
32. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.
Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C
Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464
[TBL] [Abstract][Full Text] [Related]
33. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
Butcher MJ; Waseem TC; Galkina EV
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
[TBL] [Abstract][Full Text] [Related]
34. The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature.
Qin Z
Atherosclerosis; 2012 Mar; 221(1):2-11. PubMed ID: 21978918
[TBL] [Abstract][Full Text] [Related]
35. The pathogenesis of atherosclerosis: atherogenesis and inflammation.
Munro JM; Cotran RS
Lab Invest; 1988 Mar; 58(3):249-61. PubMed ID: 3279259
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNAs at the crossroad of vascular smooth muscle cell phenotypic modulation in atherosclerosis and neointimal formation.
Fasolo F; Paloschi V; Maegdefessel L
Atherosclerosis; 2023 Jun; 374():34-43. PubMed ID: 36513554
[TBL] [Abstract][Full Text] [Related]
37. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
Madrigal-Matute J; López-Franco O; Blanco-Colio LM; Muñoz-García B; Ramos-Mozo P; Ortega L; Egido J; Martín-Ventura JL
Cardiovasc Res; 2010 May; 86(2):330-7. PubMed ID: 20154064
[TBL] [Abstract][Full Text] [Related]
38. oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4.
Kiyan Y; Tkachuk S; Hilfiker-Kleiner D; Haller H; Fuhrman B; Dumler I
J Mol Cell Cardiol; 2014 Jan; 66():72-82. PubMed ID: 24239845
[TBL] [Abstract][Full Text] [Related]
39. Emerging Roles for Neuropilin-2 in Cardiovascular Disease.
Harman JL; Sayers J; Chapman C; Pellet-Many C
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708258
[TBL] [Abstract][Full Text] [Related]
40. Osteopontin deficiency dampens the pro-atherogenic effect of uraemia.
Pedersen TX; Madsen M; Junker N; Christoffersen C; Vikeså J; Bro S; Hultgårdh-Nilsson A; Nielsen LB
Cardiovasc Res; 2013 Jun; 98(3):352-9. PubMed ID: 23455547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
